Jason Rickard Ironwood Pharmaceuticals Inc (IRWD) insider trading activity

IRWD Quotes by TradingView

Jason Rickard is SVP, Chief Operating Officer of IRONWOOD PHARMACEUTICALS INC. Currently has a direct ownership of 376,316 shares of IRWD, which is worth approximately $1.26 Million. The most recent transaction as insider was on Mar 08, 2023, when has been sold 43,668 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 376K
0% 3M change
0% 12M change
Total Value Held $1.26 Million

Jason Rickard Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 08 2023
BUY
Grant, award, or other acquisition
-
43,668 Added 10.4%
376,316 Class A Common Stock
Feb 28 2023
SELL
Open market or private sale
$197,121 $11.31 p/Share
17,429 Reduced 4.98%
332,648 Class A Common Stock
Feb 27 2023
SELL
Open market or private sale
$191,071 $11.41 p/Share
16,746 Reduced 4.57%
350,077 Class A Common Stock
Jan 17 2023
BUY
Grant, award, or other acquisition
-
18,087 Added 4.7%
366,823 Class A Common Stock
Dec 14 2022
SELL
Open market or private sale
$334,530 $12.39 p/Share
27,000 Reduced 7.19%
348,736 Class A Common Stock
Aug 15 2022
SELL
Open market or private sale
$11,699 $11.77 p/Share
994 Reduced 0.26%
375,736 Class A Common Stock
Aug 09 2022
SELL
Open market or private sale
$211,982 $11.75 p/Share
18,041 Reduced 4.57%
376,730 Class A Common Stock
Aug 09 2022
BUY
Exercise of conversion of derivative security
$210,178 $11.65 p/Share
18,041 Added 4.37%
394,771 Class A Common Stock
Aug 08 2022
SELL
Open market or private sale
$341,458 $11.6 p/Share
29,436 Reduced 7.25%
376,730 Class A Common Stock
May 23 2022
SELL
Open market or private sale
$155,676 $11.5 p/Share
13,537 Reduced 3.24%
404,074 Class A Common Stock
Mar 02 2022
BUY
Grant, award, or other acquisition
-
90,498 Added 17.81%
417,611 Class A Common Stock
Feb 28 2022
SELL
Open market or private sale
$311,921 $10.77 p/Share
28,962 Reduced 8.13%
327,113 Class A Common Stock
Jan 19 2022
BUY
Grant, award, or other acquisition
-
36,174 Added 9.22%
356,075 Class A Common Stock
Dec 16 2021
SELL
Open market or private sale
$304,560 $11.28 p/Share
27,000 Reduced 7.78%
319,901 Class A Common Stock
Nov 23 2021
SELL
Open market or private sale
$199,095 $11.58 p/Share
17,193 Reduced 4.75%
344,665 Class A Common Stock
Aug 16 2021
SELL
Open market or private sale
$9,166 $13.48 p/Share
680 Reduced 0.19%
361,858 Class A Common Stock
May 24 2021
SELL
Open market or private sale
$6,321 $12.25 p/Share
516 Reduced 0.14%
362,538 Class A Common Stock
Mar 26 2021
BUY
Grant, award, or other acquisition
-
56,372 Added 13.44%
363,054 Class A Common Stock
Feb 26 2021
SELL
Open market or private sale
$124,361 $9.11 p/Share
13,651 Reduced 4.26%
306,682 Class A Common Stock
Feb 22 2021
BUY
Grant, award, or other acquisition
-
84,951 Added 20.96%
320,333 Class A Common Stock
Nov 09 2020
SELL
Open market or private sale
$4,302 $10.92 p/Share
394 Reduced 0.17%
235,382 Class A Common Stock
JR

Jason Rickard

SVP, Chief Operating Officer
Boston, MA

Track Institutional and Insider Activities on IRWD

Follow IRONWOOD PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IRWD shares.

Notify only if

Insider Trading

Get notified when an Ironwood Pharmaceuticals Inc insider buys or sells IRWD shares.

Notify only if

News

Receive news related to IRONWOOD PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IRWD